TY - JOUR
T1 - Interferon-α promotes HLA-B-restricted presentation of conventional and alternative antigens in human pancreatic β-cells
AU - Carré, Alexia
AU - Samassa, Fatoumata
AU - Zhou, Zhicheng
AU - Perez-Hernandez, Javier
AU - Lekka, Christiana
AU - Manganaro, Anthony
AU - Oshima, Masaya
AU - Liao, Hanqing
AU - Parker, Robert
AU - Nicastri, Annalisa
AU - Brandao, Barbara
AU - Colli, Maikel L.
AU - Eizirik, Decio L.
AU - Aluri, Jahnavi
AU - Patel, Deep
AU - Göransson, Marcus
AU - Burgos Morales, Orlando
AU - Anderson, Amanda
AU - Landry, Laurie
AU - Kobaisi, Farah
AU - Scharfmann, Raphael
AU - Marselli, Lorella
AU - Marchetti, Piero
AU - You, Sylvaine
AU - Nakayama, Maki
AU - Hadrup, Sine R.
AU - Kent, Sally C.
AU - Richardson, Sarah J.
AU - Ternette, Nicola
AU - Mallone, Roberto
N1 - Copyright:
© The Author(s) 2025.
PY - 2025/1/17
Y1 - 2025/1/17
N2 - Interferon (IFN)-α is the earliest cytokine signature observed in individuals at risk for type 1 diabetes (T1D), but the effect of IFN-α on the antigen repertoire of HLA Class I (HLA-I) in pancreatic β-cells is unknown. Here we characterize the HLA-I antigen presentation in resting and IFN-α-exposed β-cells and find that IFN-α increases HLA-I expression and expands peptide repertoire to those derived from alternative mRNA splicing, protein cis-splicing and post-translational modifications. While the resting β-cell immunopeptidome is dominated by HLA-A-restricted peptides, IFN-α largely favors HLA-B and only marginally upregulates HLA-A, translating into increased HLA-B-restricted peptide presentation and activation of HLA-B-restricted CD8+ T cells. Lastly, islets of patients with T1D show preferential HLA-B hyper-expression when compared with non-diabetic donors, and islet-infiltrating CD8+ T cells reactive to HLA-B-restricted granule peptides are found in T1D donors. Thus, the inflammatory milieu of insulitis may skew the autoimmune response toward alternative epitopes presented by HLA-B, hence recruiting T cells with a distinct repertoire that may be relevant to T1D pathogenesis.
AB - Interferon (IFN)-α is the earliest cytokine signature observed in individuals at risk for type 1 diabetes (T1D), but the effect of IFN-α on the antigen repertoire of HLA Class I (HLA-I) in pancreatic β-cells is unknown. Here we characterize the HLA-I antigen presentation in resting and IFN-α-exposed β-cells and find that IFN-α increases HLA-I expression and expands peptide repertoire to those derived from alternative mRNA splicing, protein cis-splicing and post-translational modifications. While the resting β-cell immunopeptidome is dominated by HLA-A-restricted peptides, IFN-α largely favors HLA-B and only marginally upregulates HLA-A, translating into increased HLA-B-restricted peptide presentation and activation of HLA-B-restricted CD8+ T cells. Lastly, islets of patients with T1D show preferential HLA-B hyper-expression when compared with non-diabetic donors, and islet-infiltrating CD8+ T cells reactive to HLA-B-restricted granule peptides are found in T1D donors. Thus, the inflammatory milieu of insulitis may skew the autoimmune response toward alternative epitopes presented by HLA-B, hence recruiting T cells with a distinct repertoire that may be relevant to T1D pathogenesis.
UR - https://www.scopus.com/pages/publications/85216182735
U2 - 10.1038/s41467-025-55908-9
DO - 10.1038/s41467-025-55908-9
M3 - Article
C2 - 39824805
AN - SCOPUS:85216182735
SN - 2041-1723
VL - 16
JO - Nature Communications
JF - Nature Communications
M1 - 765
ER -